Mizuho Financial Group Inc. continued to hold its position in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 30,028 shares of the company’s stock at the end of the second quarter. CME Group accounts for about 0.3% of Mizuho Financial Group Inc.’s portfolio, making the stock its 2nd largest position. Mizuho Financial Group Inc.’s holdings in CME Group were worth $2,925,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of CME. Bank of Montreal Can acquired a new position in CME Group during the second quarter valued at about $35,643,000. Geode Capital Management LLC boosted its position in CME Group by 6.0% in the first quarter. Geode Capital Management LLC now owns 2,947,602 shares of the company’s stock valued at $282,588,000 after buying an additional 167,225 shares during the last quarter. Primecap Management Co. CA boosted its position in CME Group by 6.5% in the first quarter. Primecap Management Co. CA now owns 1,946,113 shares of the company’s stock valued at $186,924,000 after buying an additional 118,150 shares during the last quarter. Oakbrook Investments LLC boosted its position in CME Group by 39.8% in the second quarter. Oakbrook Investments LLC now owns 292,290 shares of the company’s stock valued at $28,469,000 after buying an additional 83,200 shares during the last quarter. Finally, SevenBridge Financial Group LLC acquired a new position in CME Group during the first quarter valued at about $481,000. Hedge funds and other institutional investors own 79.89% of the company’s stock.
Shares of CME Group Inc. (NASDAQ:CME) traded up 0.35% on Tuesday, hitting $104.09. The company had a trading volume of 637,943 shares. The company has a market cap of $35.27 billion, a price-to-earnings ratio of 26.29 and a beta of 0.83. The company has a 50 day moving average of $106.36 and a 200-day moving average of $99.85. CME Group Inc. has a 12-month low of $81.87 and a 12-month high of $110.35.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, July 28th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.03. The firm had revenue of $906 million for the quarter, compared to analyst estimates of $897.84 million. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The firm’s quarterly revenue was up 10.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.95 earnings per share. On average, analysts forecast that CME Group Inc. will post $4.43 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were given a $0.60 dividend. The ex-dividend date was Wednesday, September 7th. This represents a $2.40 annualized dividend and a yield of 2.31%. CME Group’s dividend payout ratio (DPR) is 60.61%.
CME has been the topic of a number of research reports. Credit Agricole SA lowered their price target on CME Group from $100.00 to $95.00 and set an “underperform” rating on the stock in a report on Thursday, July 14th. Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $116.00 target price on the stock in a research note on Thursday, August 4th. Jefferies Group reaffirmed a “buy” rating and issued a $118.00 target price on shares of CME Group in a research note on Thursday, October 13th. Deutsche Bank AG upped their target price on CME Group from $111.00 to $112.00 and gave the company a “buy” rating in a research note on Friday, August 5th. Finally, Keefe, Bruyette & Woods upped their target price on CME Group from $99.00 to $103.00 and gave the company a “market perform” rating in a research note on Friday, July 29th. Two analysts have rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company’s stock. CME Group presently has an average rating of “Hold” and a consensus target price of $103.27.
In other CME Group news, insider Kimberly S. Taylor sold 2,300 shares of CME Group stock in a transaction that occurred on Thursday, September 29th. The shares were sold at an average price of $106.01, for a total value of $243,823.00. Following the transaction, the insider now owns 105,558 shares in the company, valued at $11,190,203.58. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Derek Sammann sold 3,550 shares of CME Group stock in a transaction that occurred on Tuesday, August 2nd. The stock was sold at an average price of $103.20, for a total transaction of $366,360.00. Following the completion of the transaction, the insider now owns 30,896 shares in the company, valued at approximately $3,188,467.20. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by company insiders.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.